[HTML][HTML] Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk

M Ahmad, LB Weiswald, L Poulain, C Denoyelle… - Journal of Experimental …, 2023 - Springer
Cancer is the main cause of death worldwide and metastasis is a major cause of poor
prognosis and cancer-associated mortality. Metastatic conversion of cancer cells is a …

Tumor-derived systems as novel biomedical tools—turning the enemy into an ally

N Desai, P Katare, V Makwana, S Salave… - Biomaterials …, 2023 - spj.science.org
Cancer is a complex illness that presents significant challenges in its understanding and
treatment. The classic definition," a group of diseases characterized by the uncontrolled …

[HTML][HTML] Multi-component Chinese medicine formulas for drug discovery: state of the art and future perspectives

C Zhang, G Chen, G Tang, X Xu, Z Feng, Y Lu… - Acta Materia …, 2023 - scienceopen.com
For hundreds of years, the drug discovery and development industry has aimed at
identifying single components with a clear mechanism of action as desirable candidates for …

The art of finding the right drug target: emerging methods and strategies

ZC Jia, X Yang, YK Wu, M Li, D Das… - Pharmacological …, 2024 - pharmrev.aspetjournals.org
Drug targets are specific molecules in biological tissues and body fluids that interact with
drugs. Drug target discovery is a key component of drug discovery and is essential for the …

Genome-wide open reading frame profiling identifies fibroblast growth factor signaling as a driver of PD-L1 expression in head and neck squamous cell carcinoma

JE Mann, JD Smith, A Kulkarni, SK Foltin, EB Scheftz… - Oral Oncology, 2023 - Elsevier
Head and neck squamous cell carcinomas (HNSCC) are associated with significant
treatment-related morbidity and poor disease-free and disease-specific survival, especially …

Melatonin targeting non-coding RNAs in cancer: Focus on mechanisms and potential therapeutic targets

A Mafi, A Keshavarzmotamed, N Hedayati… - European journal of …, 2023 - Elsevier
Despite, melatonin is mainly known as a regulatory factor for circadian rhythm, its notable
role in other fundamental biological processes, such as redox homeostasis and …

Design and synthesis of APN and 3CLpro dual‐target inhibitors based on STSBPT with anticoronavirus activity

Y Zheng, J Feng, Y Song, Y Yu, M Ling… - Journal of Medical …, 2024 - Wiley Online Library
Coronaviruses (CoVs) have continuously posed a threat to human and animal health.
However, existing antiviral drugs are still insufficient in overcoming the challenges caused …

[HTML][HTML] CRISPR/Cas9 as a therapeutic tool for triple negative breast cancer: From bench to clinics

PK Tiwari, TH Ko, R Dubey, M Chouhan… - Frontiers in Molecular …, 2023 - frontiersin.org
Clustered regularly interspaced short palindromic repeats (CRISPR) is a third-generation
genome editing method that has revolutionized the world with its high throughput results. It …

CRISPR/Cas genome editing in triple negative breast cancer: Current situation and future directions

L Fu, Z Li, Y Ren, H Yu, B Liu, Y Qiu - Biochemical Pharmacology, 2023 - Elsevier
Triple negative breast cancer (TNBC) has been well-known to be closely associated with the
abnormal expression of both oncogenes and tumor suppressors. Although several …

[HTML][HTML] Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC

YT Chan, J Wu, Y Lu, Q Li, Z Feng, L Xu, H Yuan… - Molecular Cancer, 2024 - Springer
Background and aims Sorafenib is a major nonsurgical option for patients with advanced
hepatocellular carcinoma (HCC); however, its clinical efficacy is largely undermined by the …